Cargando…

Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis

BACKGROUND: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Isabelle, Palmero, David, Fischer Fumeaux, Céline Julie, Bonnabry, Pascal, Bouchoud, Lucie, Sadeghipour, Farshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169048/
https://www.ncbi.nlm.nih.gov/pubmed/34093016
http://dx.doi.org/10.2147/TCRM.S280938
_version_ 1783701980058746880
author Sommer, Isabelle
Palmero, David
Fischer Fumeaux, Céline Julie
Bonnabry, Pascal
Bouchoud, Lucie
Sadeghipour, Farshid
author_facet Sommer, Isabelle
Palmero, David
Fischer Fumeaux, Céline Julie
Bonnabry, Pascal
Bouchoud, Lucie
Sadeghipour, Farshid
author_sort Sommer, Isabelle
collection PubMed
description BACKGROUND: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A previous study showed a concentration non-conformity of 34% of on-ward PN preparations potentially resulting in under- or overfeeding of the patients. OBJECTIVE: The objectives were to perform preliminary risk analyses (PRA) in preparation for our hospital’s transition to universal central pharmacy PN compounding. METHODS: A working group including pharmacists, neonatologists, nurses, and pharmacy technicians performed two PRA. The risks of 9 management steps of the PN process were identified, evaluated, and quoted. A comparison of the number of risks and their criticality index (CI) was conducted. RESULTS: A total of 36 and 39 risks were identified for PN preparation in the NICU and the pharmacy, respectively. For the NICU, ten risks (28%) had an “acceptable” CI, 15 risks (42%) were “under control” and eleven (31%) were defined as “non-acceptable”. For the pharmacy, 14 risks (36%) had an “acceptable” CI, 19 risks (49%) were “under control” and six (15%) were defined as “non-acceptable”. Risks directly related to the preparation process, including the steps preparation hood, PN preparation and analytical quality control, represented a cumulated CI of 145 for eleven NICU-risks vs 108 for twelve pharmacy risks (−26%). The implementation of immediate improvement measures, eg, an electronic prescription form, reduces the total CI by 5.7% and 2.2% for the NICU and the pharmacy, respectively. CONCLUSION: This PRA highlighted the safety differences between PN preparation in the NICU vs the pharmacy at our institution, and facilitated our moving forward with a process change that should improve the care of our neonatal patients. Nevertheless, long-term improvement measures have to be implemented to further reduce risks related to the PN management process.
format Online
Article
Text
id pubmed-8169048
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81690482021-06-03 Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis Sommer, Isabelle Palmero, David Fischer Fumeaux, Céline Julie Bonnabry, Pascal Bouchoud, Lucie Sadeghipour, Farshid Ther Clin Risk Manag Original Research BACKGROUND: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A previous study showed a concentration non-conformity of 34% of on-ward PN preparations potentially resulting in under- or overfeeding of the patients. OBJECTIVE: The objectives were to perform preliminary risk analyses (PRA) in preparation for our hospital’s transition to universal central pharmacy PN compounding. METHODS: A working group including pharmacists, neonatologists, nurses, and pharmacy technicians performed two PRA. The risks of 9 management steps of the PN process were identified, evaluated, and quoted. A comparison of the number of risks and their criticality index (CI) was conducted. RESULTS: A total of 36 and 39 risks were identified for PN preparation in the NICU and the pharmacy, respectively. For the NICU, ten risks (28%) had an “acceptable” CI, 15 risks (42%) were “under control” and eleven (31%) were defined as “non-acceptable”. For the pharmacy, 14 risks (36%) had an “acceptable” CI, 19 risks (49%) were “under control” and six (15%) were defined as “non-acceptable”. Risks directly related to the preparation process, including the steps preparation hood, PN preparation and analytical quality control, represented a cumulated CI of 145 for eleven NICU-risks vs 108 for twelve pharmacy risks (−26%). The implementation of immediate improvement measures, eg, an electronic prescription form, reduces the total CI by 5.7% and 2.2% for the NICU and the pharmacy, respectively. CONCLUSION: This PRA highlighted the safety differences between PN preparation in the NICU vs the pharmacy at our institution, and facilitated our moving forward with a process change that should improve the care of our neonatal patients. Nevertheless, long-term improvement measures have to be implemented to further reduce risks related to the PN management process. Dove 2021-05-28 /pmc/articles/PMC8169048/ /pubmed/34093016 http://dx.doi.org/10.2147/TCRM.S280938 Text en © 2021 Sommer et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sommer, Isabelle
Palmero, David
Fischer Fumeaux, Céline Julie
Bonnabry, Pascal
Bouchoud, Lucie
Sadeghipour, Farshid
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
title Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
title_full Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
title_fullStr Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
title_full_unstemmed Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
title_short Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
title_sort parenteral nutrition process management for newborn and preterm infants – a preliminary risk analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169048/
https://www.ncbi.nlm.nih.gov/pubmed/34093016
http://dx.doi.org/10.2147/TCRM.S280938
work_keys_str_mv AT sommerisabelle parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis
AT palmerodavid parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis
AT fischerfumeauxcelinejulie parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis
AT bonnabrypascal parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis
AT bouchoudlucie parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis
AT sadeghipourfarshid parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis